|
US3882246A
(en)
|
1971-05-21 |
1975-05-06 |
Merck & Co Inc |
Treatment of skeletal muscle disorders with cyclobenzaprine
|
|
US4968507A
(en)
|
1984-06-20 |
1990-11-06 |
Merck & Co., Inc. |
Controlled porosity osmotic pump
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
FR2635461B1
(fr)
|
1988-08-18 |
1992-01-17 |
Adir |
Utilisation de derives tricycliques pour l'obtention de medicaments destines au traitement du stress
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
SG47101A1
(en)
|
1992-07-31 |
1998-03-20 |
Us Bioscience |
Crystalline amifostine compositions and methods for the preparation and use of same
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
PT693924E
(pt)
|
1993-02-22 |
2004-09-30 |
American Biosciences |
Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
|
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US5354566A
(en)
|
1993-06-02 |
1994-10-11 |
Kraft General Foods, Inc. |
Preparation of yeast-leavened dough crusts
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
US5834025A
(en)
|
1995-09-29 |
1998-11-10 |
Nanosystems L.L.C. |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
|
|
US6649186B1
(en)
|
1996-09-20 |
2003-11-18 |
Ethypharm |
Effervescent granules and methods for their preparation
|
|
US20030077227A1
(en)
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
|
WO1999018937A1
(en)
|
1997-10-16 |
1999-04-22 |
Merck & Co., Inc. |
New cyclobenzaprine composition
|
|
EP1077683B1
(en)
|
1998-05-14 |
2002-12-11 |
Alza Corporation |
Antidepressant therapy
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US7374779B2
(en)
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
HK1047693A1
(zh)
*
|
1999-08-13 |
2003-03-07 |
Vela Pharmaceuticals Inc. |
治疗全身性焦虑障碍的环苯扎林及其组合物
|
|
PT1202722E
(pt)
*
|
1999-08-13 |
2005-11-30 |
L & L Technologies Llc |
Usos para o tratamento ou prevencao de disturbios do sono usando doses muito baixas de ciclobenzaprina
|
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
|
AU2001261744A1
(en)
|
2000-05-19 |
2001-12-03 |
Npd Llc |
Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
|
|
DK1441708T3
(da)
|
2001-11-05 |
2009-07-06 |
Krele Pharmaceuticals Llc |
Sammensætninger og fremgangsmåder til forögelse af föjelighed med terapier ved anvendelse af aldehyddehydrogenase-inhibitorer og behandling af alkoholisme
|
|
US7659253B2
(en)
|
2002-02-22 |
2010-02-09 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
|
US7700561B2
(en)
|
2002-02-22 |
2010-04-20 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
|
US7105486B2
(en)
|
2002-02-22 |
2006-09-12 |
New River Pharmaceuticals Inc. |
Abuse-resistant amphetamine compounds
|
|
CA2503381A1
(en)
|
2002-10-25 |
2004-05-13 |
Collegium Pharmaceutical, Inc. |
Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof
|
|
EP2359859A1
(en)
|
2002-12-09 |
2011-08-24 |
Abraxis BioScience, LLC |
Compositions comprising albumin nanoparticles and methods of delivery of pharmacological agents
|
|
US8688385B2
(en)
|
2003-02-20 |
2014-04-01 |
Mayo Foundation For Medical Education And Research |
Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
|
|
US20050059656A1
(en)
|
2003-04-07 |
2005-03-17 |
Cornell Research Foundation, Inc. |
Compositions and methods for protecting against mitochondria component-mediated pathology
|
|
BRPI0410792B8
(pt)
|
2003-05-29 |
2021-05-25 |
New River Pharmaceuticals Inc |
compostos de anfetamina resistentes à dependencia
|
|
JP2007510642A
(ja)
|
2003-11-03 |
2007-04-26 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
中枢神経系障害の治療のための新規ノルエピネフリン再取込み阻害薬
|
|
US20050143350A1
(en)
|
2003-11-19 |
2005-06-30 |
Seed John C. |
Combination drug therapy to treat obesity
|
|
CA2548281C
(en)
|
2003-12-09 |
2013-11-12 |
Medcrystalforms, Llc |
Method of preparation of mixed phase co-crystals with active agents
|
|
US7658945B2
(en)
|
2004-02-17 |
2010-02-09 |
Transcept Pharmaceuticals, Inc. |
Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
|
|
TW200531680A
(en)
|
2004-03-03 |
2005-10-01 |
Merz Pharma Gmbh & Co Kgaa |
Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease
|
|
US8216610B2
(en)
|
2004-05-28 |
2012-07-10 |
Imaginot Pty Ltd. |
Oral paracetamol formulations
|
|
US20070196364A1
(en)
|
2004-07-27 |
2007-08-23 |
Human Genome Sciences, Inc. |
Pharmaceutical Formulation and Process
|
|
US7532935B2
(en)
|
2005-07-29 |
2009-05-12 |
Cyberonics, Inc. |
Selective neurostimulation for treating mood disorders
|
|
US7994220B2
(en)
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
|
US20090069267A1
(en)
|
2006-01-17 |
2009-03-12 |
Abrams Daniel J |
Central administration of stable formulations of therapeutic agents for cns conditions
|
|
US20080146672A1
(en)
|
2006-12-08 |
2008-06-19 |
Denton Marcia Marye |
Topical Eutectic Anesthetic Composition for Oral or Dermal Tissue
|
|
AU2008248382B2
(en)
|
2007-05-07 |
2013-07-18 |
Chelsea Therapeutics, Inc. |
Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disorders
|
|
EP2170064A4
(en)
|
2007-06-22 |
2010-08-04 |
Merck Sharp & Dohme |
6,5-pyrrolopiperidine tachykinin receptor antagonists
|
|
NZ583193A
(en)
|
2007-07-23 |
2012-05-25 |
Biotie Therapies Inc |
Treatment of post-traumatic stress disorder with nepicastat
|
|
US20090060983A1
(en)
|
2007-08-30 |
2009-03-05 |
Bunick Frank J |
Method And Composition For Making An Orally Disintegrating Dosage Form
|
|
ES2731881T3
(es)
|
2007-09-25 |
2019-11-19 |
Formulex Pharma Innovations Ltd |
Composiciones que comprenden compuestos activos lipófilos y método para su preparación
|
|
US20100247649A1
(en)
|
2007-10-30 |
2010-09-30 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide
|
|
US20090148532A1
(en)
|
2007-12-06 |
2009-06-11 |
Venkatesh Gopi M |
Preparation of controlled release skeletal muscle relaxant dosage forms
|
|
CA2905541C
(en)
|
2008-01-09 |
2020-02-11 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
|
|
WO2009100222A1
(en)
|
2008-02-08 |
2009-08-13 |
Qps Llc |
Non-polymeric compositions for controlled drug delivery
|
|
US9314469B2
(en)
|
2008-05-05 |
2016-04-19 |
Tonix Pharma Holdings Limited |
Method for treating neurocognitive dysfunction
|
|
JP5380909B2
(ja)
|
2008-05-30 |
2014-01-08 |
株式会社ブリヂストン |
金型及び樹脂発泡成形品の成形方法
|
|
US20100266682A1
(en)
|
2008-12-10 |
2010-10-21 |
Nipun Davar |
Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same
|
|
EP2233134A1
(en)
|
2009-03-27 |
2010-09-29 |
McNeil AB |
Multi-portion intra-oral dosage form with organoleptic properties
|
|
US20100247586A1
(en)
|
2009-03-27 |
2010-09-30 |
Andreas Hugerth |
Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
|
|
US8784781B2
(en)
|
2009-09-24 |
2014-07-22 |
Mcneil-Ppc, Inc. |
Manufacture of chewing gum product with radiofrequency
|
|
HRP20171739T1
(hr)
|
2009-11-20 |
2018-03-09 |
Tonix Pharma Holdings Limited |
Postupci i kompozicije za liječenje simptoma povezanih s posttraumatskim stresnim poremećajem korištenjem ciklobenzaprina
|
|
US20110319389A1
(en)
|
2010-06-24 |
2011-12-29 |
Tonix Pharmaceuticals, Inc. |
Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
|
|
KR20130132774A
(ko)
|
2010-09-01 |
2013-12-05 |
토닉스 파마슈티컬스, 아이엔씨. |
코카인 중독에 대한 치료
|
|
US11998516B2
(en)
|
2011-03-07 |
2024-06-04 |
Tonix Pharma Holdings Limited |
Methods and compositions for treating depression using cyclobenzaprine
|
|
ITMI20110558A1
(it)
|
2011-04-06 |
2012-10-07 |
Campiglio Consulting Srl |
Composizione farmaceutica contenente ciclobenzaprina adatta alla somministrazione endonasale
|
|
PT2861223T
(pt)
|
2012-06-15 |
2022-11-07 |
Tonix Pharmaceuticals Inc |
Composições e métodos de absorção transmucosa
|
|
EP3369730B1
(en)
|
2012-11-05 |
2020-08-05 |
Emory University |
7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto
|
|
HUE047547T2
(hu)
|
2013-03-15 |
2020-04-28 |
Tonix Pharma Holdings Ltd |
Ciklobenzaprin-hidroklorid és mannit eutektikus formulációi
|
|
US20160015818A1
(en)
|
2014-07-18 |
2016-01-21 |
Medipath, Inc. |
Compositions and methods for physiological delivery using cannabidiol
|
|
SG10201902203VA
(en)
|
2014-09-18 |
2019-04-29 |
Tonix Pharma Holdings Ltd |
Eutectic formulations of cyclobenzaprine hydrochloride
|
|
WO2019116091A1
(en)
|
2017-12-11 |
2019-06-20 |
Tonix Pharma Holdings Limited |
Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions
|
|
US20230414536A1
(en)
|
2022-06-21 |
2023-12-28 |
Tonix Pharmaceuticals Holding Corp. |
CYCLOBENZAPRINE TREATMENT FOR POST-ACUTE SEQUELAE OF (SARS)-CoV-2 INFECTION (PASC)
|